Preliminary Phase 2 Results to be Presented at Biotech Showcase 2019

January 2, 2019 – Silenseed to present early Phase 2 clinical results in stage 3 pancreatic cancer. Presentation will include very preliminary clinical results from the first 11 patients enrolled in the company’ PROTACT Phase 2 clinical trial. Presentation will be given at the Biotech Showcase, the event claimed to be “The investor conference that drives the future of drug development”, at Wednesday, 11:00 AM January 9, 2019 Track: Franciscan C (Ballroom Level), Hilton Union Square San Francisco

Share this post